The company focuses on developing drugs for unmet clinical needs worldwide, with all of its products being first-in-class. Advaccine is a developer of viral vaccine technology, and currently has vaccines for hepatitis B, respiratory syncytial virus, type 1 diabetes, and coronavirus in their research pipeline. Their mission is to enable healthcare providers to deliver effective treatments to patients.